TACR1 and kidney disorder: However, the possibility, that the change of SP level is derived from damage reduction by statins and NK1R antagonist, cannot be ignored, because endogenous SP is injury inducible neurotransmitter and the protective effect of statin in kidney disease is associated with SP-independent inflammation and macrophage polarization (31, 32).